can tirzepatide cause blindness Blindness? What to Know Tirzepatide and Macular Degeneration: Current

Currently, kidney protective effects of GLP-1RAs are primarily supported by cardiovascular outcome trials

You may be eligible for the medication if you want to lose weight and you have: Obesity (Body mass index 30 or more) Overweight (BMI 27 or more) with at least one weight-related comorbidity such as hypertension (high blood pressure), hyperlipidemia, hypercholesterolemia (high cholesterol levels), or heart disease

Its FDA-approved for weight loss and still being studied for diabetes

Measuring 10 units for the 0.25mg starting dose is easier than measuring 5 units, especially if you are new to peptide injections and still getting comfortable with syringe technique

Strength train regularly Muscle mass improves insulin sensitivity and amplifies GLP-1 effectiveness

A phase IV non-inferiority trial, known as DISCOMS, demonstrated that people with MS who were over the age of 55 years and had stable disease (no relapse for 5 years) on low-efficacy DMTs could safely discontinue treatment, although a small proportion (16 of 131 participants) did experience new or expanding brain MRI lesions 119